Nifty opened at 16078 with a gap up of 65 points. The index initially went down for the first five minutes of trading and recorded its intraday low at 15990. Prices have started moving up after that. Minor dips in between quickly find support and bulls use these opportunities to buy more. The intraday range was wide today. Prices have moved up more than 400 points from its day low to day high , recorded its intraday high at 16418.05, and finally closed at 16345.35 with a gain of 331.90 points or 2.07% up. All the sectoral indices have seen an upside move today except the METAL that ended with a loss of 0.34%. FINANCIAL,MEDIA, AUTO ,and REALTY outperformed today and closed wit h impressive gains.

The short-term trend is changing to sideways today as the index broke above 16200 resistance and closed higher. The volatility index ‘INDIA VIX’ has seen a minor decline today but still moving around 28 which is very high. The first sign of low volatile markets will come when the VIX moves below 20. Strong support should emerge around 15500 while strong resistance is visible inside the 16800 – 16900 range. Carry forward traders should step aside while intraday traders should look for a buying opportunity.


BANK NIFTY opened at 33278.90 with a ga p up of just 72 points. The index first consolidated in a narrow range till the afternoon and recorded its intraday low at 32948.90. Prices broke out higher and saw a sharp rally to record its intraday high at 33969.50. The index finally closed at 33891.25 with a gain of 685 points. PVT and PSU BANKS both indices have performed almost same today, saw a sharp intraday rally and closed higher by nearly 2%. Within the index, in terms of points, HDFC BANK contributed the highest on the upside followed by SBIN.

It wiII be sideways if prices closed above 34000. Carry forward traders shouId avoid trading the index and wait markets to stabilize first. However, intraday traders should look for a buying opportunity on a dip or consolidation breakouts.


NAUKRI 4563 BUY The stock is on the verge of giving the breakout on the intraday as well as the daily chart. The stock can be bought  with a stop loss of 4500 and for the target of 4620.
COFORGE 4556 SELL The  immediate trend of the script is bearish. There is a negative  cross over of moving averages  as well as of the indicators therefore  it can be sell below 4550 with a stop loss of 4600 and target  of 4480.


Stock Name Strike Price Buy/Sell CMP Initiation Stop Loss Target Remarks
RELIANCE 2380 CE BUY 55 CMP 40 85 OI Increase
Long Buildup Short Buildup
Stocks Price Price% OI % OI Stocks Price Price% OI % OI
APOLLOHOSP.Mar 31 4738.55 0.06 1.35 2114000 COFORGE.Mar 31 4591.6 -4.57 21.71 602000
IPCALAB.Mar 31 1005.15 0.08 2.09 878400 PETRONET.Mar 31 213.2 -3.83 5.38 17340000
ABB.Mar 31 2142.8 0.11 5.91 331500 BOSCHLTD.Mar 31 14268 -2.34 10.29 143650
ABBOTINDIA.Mar 31 17790 0.12 1.39 32750 ONGC.Mar 31 172.85 -2.29 17.74 32447800
GSPL.Mar 31 269.65 0.13 26.28 1887000 GAIL.Mar 31 151.4 -2.1 11.93 25979900
                                                                        Short Covering                                                                       Long Unwinding
UPL.Mar 31 726.85 0.03 -0.81 23760100 NMDC.Mar 31 152.25 -0.36 -0.28 64018500
ALKEM.Mar 31 3291.5 0.4 -2.29 213600 MGL.Mar 31 762 -0.03 -0.36 3362400
BHEL.Mar 31 50.9 1.19 -0.36 1.01E+08
TATAPOWER.Mar 31 230.25 1.21 -0.39 91482750
GNFC.Mar 31 617.75 1.35 -0.7 2211300


Stocks Price %Chg Total Qty Delivery Del % % Change
Sectors Price Change % Quantity
Marico Limited 492.6 0.4 2526968 0 76.34 Nifty50 16345.35 2.07 77184
Whirlpool 1589.9 1.31 242979 0 70.81 Niftybank 33815.45 1.98 77184
Alkem 3276.6 0.34 122653 0 67.35 Nifty it 35440.55 1.1 77184
Pfizer Ltd. 4424.1 0.95 69144 0 67.12 Nifty Fmcg 34486.95 1.41 77184
Icici Lombard General In 1236.1 1.52 1380187 0 67 Nifty Pharma 13059.25 1.67 77184
Itc Ltd. 229.25 1.04 42294906 0 65.25 Nifty Realty 418.85 3.05 77184
Hindustan Unilever Ltd 1997.9 2.51 2879079 0 64.84 Nifty Auto 9832.35 2.85 77184
Colgate Palmolive (india 1449.05 1.3 607334 0 64.49 Nifty Metal 6024.6 -0.34 77184
Container Corp Of India 594.6 4.42 700987 0 63.86 Nifty Media 2125.35 4.05 77184
Hdfc Ltd. 2194.4 1.98 6114047 0 62.56 Nifty Financial Services 15845.5 2.04 77184


   Domestic                                                                                                                                                  International
INR: Industrial Production (YoY) (Jan) on 11th March, 2022

INR: Manufacturing Output (MoM) (Jan) on 11th March, 2022

•USD:  Core CPI (MoM) (Feb) on 10th March, 2022

•USD:  Initial Jobless Claims on 10th March, 2022


  • Zydus Lifesciences on Wednesday said it has received approval from the US health regulator to market Nitroglycerin Sublingual tablets, used to treat chest pain, in the American market. The company has received approval from the US Food and Drug Administration (USFDA) for the drug in strengths of 0.3 mg, 0.4 mg and 0.6 mg, Zydus Lifesciences said in a statement.
  • L&T Construction has won a significant order from Delhi Metro Rail Corporation (DMRC) to design and construct the underground metro project of Phase-IV of Delhi MRTS. L&T Construction is the construction arm of infrastructure major Larsen & Toubro (L&T). The major scope of work for the project includes design and construction of a 5-km twin tunnel, cut and cover tunnel box, underground ramp and four underground stations namely Chhatarpur, Chhatarpur Mandir, IGNOU and Neb Sarai with associated works of Aerocity to Tughlaqabad corridor.
  • Kajaria Ceramics on Wednesday announced the launch of its largest store in the country to sell tiles and bathware products. The 100th Kajaria Eternity World showroom, which has come up in an 11,000 square feet area in Lajpat Nagar, offers tiles and Kerovit bathware products under one roof.
  • Indian pharmaceutical major Dr. Reddy’s Laboratories Ltd said on Wednesday it was focused on business continuity in and around Russia, as Indian drug exporters brace for temporary disruptions to sales due to the Ukraine crisis.

Source: Economic Times,  Indian Express  ,Business Today, Livemint, Business Standard, Bloomberg Quint.


Company Name Purpose Ex-Date Company Name Purpose Ex-Date
BCLIL Interim Dividend 10-Mar-22 WARDINMOBI General 10-Mar-22
DSSL Employees Stock Option Plan 10-Mar-22 AMARJOTHI General 11-Mar-22
HKG General 10-Mar-22 DHANVARSHA Preferential Issue of shares 11-Mar-22
INDINFO General 10-Mar-22 GAIL Interim Dividend;General 11-Mar-22
INDLEASE General 10-Mar-22 HVL General 11-Mar-22
JINDALSTEL Interim Dividend 10-Mar-22 KESARPE General 11-Mar-22
KABRADG General 10-Mar-22 MIRCH Preferential Issue of shares 11-Mar-22
MOTOGENFIN General 10-Mar-22 RACE General 11-Mar-22
PARACABLES General 10-Mar-22 SHREYASI General 11-Mar-22
RAMSARUP Audited Results;Quarterly Results 10-Mar-22 DATASOFT General 12-Mar-22
SAMPRE Right Issue of Equity Shares;Pref. Issue 10-Mar-22 GGENG General 12-Mar-22
SPANDANA General 10-Mar-22 MDRNSTL Quarterly Results 12-Mar-22
TARC General 10-Mar-22 NBL General 12-Mar-22


Company Name Ex-Date Purpose Company Name Ex-Date Purpose
7TEC 10-Mar-22 Interim Dividend – Rs. – 1.0000 ULTRACAB 10-Mar-22 Bonus issue 1:2
ADVIKCA 10-Mar-22 Right Issue of Equity Shares VISHAL 10-Mar-22 Bonus issue 2:1
BCLENTERPR 10-Mar-22 Stock  Split From Rs.10/- to Rs.1/- SRTRANSFIN 11-Mar-22 Interim Dividend – Rs. – 12.0000
BCLENTERPR 10-Mar-22 Bonus issue 1:1 ARIHCAPM 14-Mar-22 Interim Dividend – Rs. – 0.7500
EIDPARRY 10-Mar-22 Interim Dividend – Rs. – 5.5000 DICIND 14-Mar-22 Final Dividend – Rs. – 3.0000
MUL 10-Mar-22 Stock  Split From Rs.10/- to Rs.1/- DICIND 14-Mar-22 Special Dividend – Rs. – 2.0000
RAINBOWF 10-Mar-22 Right Issue of Equity Shares INFIBEAM 14-Mar-22 Bonus issue 1:1
ULTRACAB 10-Mar-22 Stock  Split From Rs.10/- to Rs.2/- NLCINDIA 14-Mar-22 Interim Dividend – Rs. – 1.5000

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Israil Khan, Elite Wealth Limited,
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit
Company-Specific Disclosures
Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting, or emailing with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail
Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.
Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.
Country Specific Disclosures
India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone:011-43035555, Facsimile: 011-22795783 and Website:
EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
1. Reports
a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
2. Compensation
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(d) EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(e) EWL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report.
3 In respect of Public Appearances
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL